Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly M Chin

Showing results (1-10 of 68) with videos related to

Pageof 7
Sort By:
Pulmonary Circulation|February 1, 2018
Lessons from the COMPASS-3 StudyTrushil Shah, Kelly M Chin
The American Journal of Cardiology|August 28, 2012
Characterizing the right ventricle: advancing our knowledgeKelly M Chin, Gerry Coghlan
Circulation|May 11, 2026
Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection FractionSatyam Sarma, Kelly M Chin
Circulation|March 29, 2026
Stepping into a New Era - Sotatercept for the Treatment of Cpc-PH from HFpEFSatyam Sarma, Kelly M Chin
Journal of the American College of Cardiology|April 19, 2008
Pulmonary arterial hypertensionKelly M Chin, Lewis J Rubin
Circulation|February 13, 2023
Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?Kelly M Chin, Patricia Santiago-Munoz
Drug Design, Development and Therapy|November 30, 2016
Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapyElizabeth Ashley Hardin, Kelly M Chin
Chest|December 15, 2006
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?Kelly M Chin, Richard N Channick, Lewis J Rubin
Coronary Artery Disease|January 18, 2005
The right ventricle in pulmonary hypertensionKelly M Chin, Nick H S Kim, Lewis J Rubin
Pulmonary Circulation|December 7, 2020
Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot studyAdetoun Sodimu, Sonja Bartolome, Oluwatosin P Igenoza, et al.
Pageof 7

Showing results (1-10 of 68) with videos related to

Sort By:
Pageof 7
Pulmonary Circulation|February 1, 2018
Lessons from the COMPASS-3 StudyTrushil Shah, Kelly M Chin
The American Journal of Cardiology|August 28, 2012
Characterizing the right ventricle: advancing our knowledgeKelly M Chin, Gerry Coghlan
Circulation|May 11, 2026
Stepping Into a New Era: Sotatercept for the Treatment of Combined Precapillary and Postcapillary Pulmonary Hypertension From Heart Failure With Preserved Ejection FractionSatyam Sarma, Kelly M Chin
Circulation|March 29, 2026
Stepping into a New Era - Sotatercept for the Treatment of Cpc-PH from HFpEFSatyam Sarma, Kelly M Chin
Journal of the American College of Cardiology|April 19, 2008
Pulmonary arterial hypertensionKelly M Chin, Lewis J Rubin
Circulation|February 13, 2023
Pregnancy and Congenital Heart Disease-Associated Pulmonary Hypertension: Are Outcomes Improving?Kelly M Chin, Patricia Santiago-Munoz
Drug Design, Development and Therapy|November 30, 2016
Selexipag in the treatment of pulmonary arterial hypertension: design, development, and therapyElizabeth Ashley Hardin, Kelly M Chin
Chest|December 15, 2006
Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?Kelly M Chin, Richard N Channick, Lewis J Rubin
Coronary Artery Disease|January 18, 2005
The right ventricle in pulmonary hypertensionKelly M Chin, Nick H S Kim, Lewis J Rubin
Pulmonary Circulation|December 7, 2020
Hemodynamic effects of fluoxetine in pulmonary arterial hypertension: an open label pilot studyAdetoun Sodimu, Sonja Bartolome, Oluwatosin P Igenoza, et al.
Pageof 7